JW Pharmaceutical Corporation (KRX:001060)

South Korea · Delayed Price · Currency is KRW

27,850

+450 (1.64%)

Last updated: Aug 31, 2026, 2:36 PM KST

JW Pharmaceutical Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	820,862	775,298	719,376	748,527	684,351	606,585
Revenue Growth	10.50%	7.77%	-3.89%	9.38%	12.82%	10.82%
Gross Profit	388,220	359,314	323,498	335,542	287,955	234,376
Operating Income	107,817	87,877	82,733	96,631	60,490	30,848
Net Income	100,417	60,648	65,040	37,006	31,892	-967.85
Earnings Per Share	4453.47	2676.46	2644.00	1554.67	1373.14	-41.70
EPS Growth	109.08%	1.23%	70.07%	13.22%	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	102,084	61,341	32,551	94,196	149,678	65,666
Total Debt	71,750	54,635	91,726	170,280	209,542	245,145
Net Cash (Debt)	30,334	6,706	-59,175	-76,084	-59,864	-179,479
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	1345.29	295.95	-2405.58	-3196.37	-2577.51	-7733.47

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	134,478	96,396	79,392	87,157	56,764	18,124
Capital Expenditures	-11,672	-11,772	-8,313	-27,286	-9,919	-7,467
Free Cash Flow	122,806	84,625	71,079	59,871	46,845	10,657
Free Cash Flow Growth	191.35%	19.06%	18.72%	27.81%	339.56%	-78.97%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	47.29%	46.34%	44.97%	44.83%	42.08%	38.64%
Operating Margin	13.13%	11.34%	11.50%	12.91%	8.84%	5.08%
Pretax Margin	14.05%	11.46%	11.46%	7.33%	6.63%	3.38%
Profit Margin	12.23%	7.82%	9.04%	4.94%	4.66%	-0.16%
FCF Margin	14.96%	10.91%	9.88%	8.00%	6.84%	1.76%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	650.000	-	-	-	-	-
Dividend Per Share Growth	0%	-	-	-	-	-
Dividend Yield	2.37%	-	-	-	-	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	6.33	9.65	8.64	22.39	13.16	-
Forward PE	-	6.18	6.50	14.34	10.40	26.79
P/FCF Ratio	5.24	6.91	7.90	13.84	8.96	47.45
PS Ratio	0.78	0.75	0.78	1.11	0.61	0.83